A half-century of VEGFA: from theory to practice.
作者信息
Quaggin Susan E
机构信息
Feinberg Cardiovascular & Renal Research Institute, and.
Division of Nephrology, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
出版信息
J Clin Invest. 2024 Aug 1;134(15):e184205. doi: 10.1172/JCI184205.
Abstract
摘要
相似文献
1
A half-century of VEGFA: from theory to practice.
J Clin Invest. 2024 Aug 1;134(15):e184205. doi: 10.1172/JCI184205.
2
Vascular endothelial growth factor.
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):789-91. doi: 10.1161/ATVBAHA.108.179663. Epub 2009 Jan 22.
3
A conversation with Napoleone Ferrara.
J Clin Invest. 2014 Aug;124(8):3275-6. doi: 10.1172/JCI77540. Epub 2014 Aug 1.
4
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.
Nat Med. 2010 Oct;16(10):1107-11. doi: 10.1038/nm1010-1107.
5
Judah Folkman leaves expanding legacy.
J Natl Cancer Inst. 2008 Mar 19;100(6):380-1. doi: 10.1093/jnci/djn072. Epub 2008 Mar 11.
6
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. 1989.
Biochem Biophys Res Commun. 2012 Aug 31;425(3):540-7. doi: 10.1016/j.bbrc.2012.08.021.
7
Anti-angiogenesis in cancer; met and unmet goals - an interview with Robert Kerbel by Francesco Bertolini.
Int J Dev Biol. 2011;55(4-5):395-8. doi: 10.1387/ijdb.103217fb.
8
From the discovery of vascular endothelial growth factor to the introduction of avastin in clinical trials - an interview with Napoleone Ferrara by Domenico Ribatti.
Int J Dev Biol. 2011;55(4-5):383-8. doi: 10.1387/ijdb.103216dr.
9
Napoleone Ferrara and the saga of vascular endothelial growth factor.
Endothelium. 2008 Jan-Feb;15(1):1-8. doi: 10.1080/10623320802092377.
10
The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
Br J Haematol. 2005 Feb;128(3):303-9. doi: 10.1111/j.1365-2141.2004.05291.x.
引用本文的文献
1
Elucidating the Neuroprotective Mechanisms of G-3702 in Ischemic Stroke via Integrated Metabolomics and Computational Approaches.
CNS Neurosci Ther. 2025 Apr;31(4):e70352. doi: 10.1111/cns.70352.
本文引用的文献
1
Biology and therapeutic targeting of vascular endothelial growth factor A.
Nat Rev Mol Cell Biol. 2023 Nov;24(11):816-834. doi: 10.1038/s41580-023-00631-w. Epub 2023 Jul 25.
2
VEGF in Signaling and Disease: Beyond Discovery and Development.
Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021.
3
ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.
J Am Soc Nephrol. 2016 Jan;27(1):120-31. doi: 10.1681/ASN.2014121165. Epub 2015 Jun 2.
4
Angiogenesis and lymphangiogenesis in inflammatory skin disorders.
J Am Acad Dermatol. 2015 Jul;73(1):144-53. doi: 10.1016/j.jaad.2015.03.041. Epub 2015 Apr 25.
5
Atypical hemolytic-uremic syndrome.
N Engl J Med. 2009 Oct 22;361(17):1676-87. doi: 10.1056/NEJMra0902814.
6
VEGF inhibition and renal thrombotic microangiopathy.
N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.
7
Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
Respir Res. 2006 Oct 17;7(1):128. doi: 10.1186/1465-9921-7-128.
8
Role of angiogenesis in cardiovascular disease: a critical appraisal.
Circulation. 2005 Sep 20;112(12):1813-24. doi: 10.1161/CIRCULATIONAHA.105.535294.
9
Vascular endothelial growth factor: basic science and clinical progress.
Endocr Rev. 2004 Aug;25(4):581-611. doi: 10.1210/er.2003-0027.
10
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
Zotero 插件